| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.6M | +251.5% |
| Cost of Revenue | $12.2M | +136.1% |
| Gross Profit | $8.5M | +1084.7% |
| R&D Expense | $2.5M | +332.5% |
| SG&A Expense | $10.2M | +96.7% |
| Operating Income | -$19.0M | +8.2% |
| Pre-tax Income | -$19.2M | +8.3% |
| Net Income | -$19.2M | +8.6% |
| EPS (Basic) | -$0.11 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $467K | -76.9% |
| Accounts Receivable | $4.5M | +171.1% |
| Inventory | $10.2M | +61.3% |
| Current Assets | $27.4M | +49.1% |
| Total Assets | $42.4M | +66.4% |
| Current Liabilities | $21.3M | +130.1% |
| Total Liabilities | $28.9M | +158.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.5M | +30.0% |
| Capital Expenditures | $661K | -76.1% |
| Investing Cash Flow | -$661K | +71.2% |
| Financing Cash Flow | $9.4M | -43.7% |
| Free Cash Flow | -$10.2M | +37.8% |
| +31.3% |
| EPS (Diluted) | -$0.11 | +31.3% |
| Stockholders' Equity |
| $13.5M |
| -5.9% |